Head and Neck Cancer Archives

Active Surveillance May be an Effective Option for Low-risk Thyroid Cancer

Cara Martinez - September 15, 2022

Why Taking a Less Personalized Approach May Increase Access to Cancer...

Laurent Levy - February 2, 2022

KEYNOTE-122: Pembrolizumab vs Chemotherapy in Platinum-Pretreated Nasopharyngeal Carcinoma

Editorial Team - September 20, 2021

Scientist working in the biosafety cabinet

Significant Survival Benefit for Head & Neck Cancer Patients Receiving Neoadjuvant...

Editorial Team - June 28, 2021

Study Confirms Safety of Head and Neck Cancer Surgery During the...

Peter Hofland, Ph.D - December 21, 2020

Survival in Head and Neck Cancer Patients Improved by Hyperfractionated Radiotherapy

Editorial Team - September 28, 2013

Combination of EGFR and COX-2 Inhibitors may Prevent Head and Neck...

Editorial Team - February 20, 2013

Photodynamic Therapy Shows Efficacy in Head and Neck Cancers

Peter Hofland, Ph.D - November 1, 2001

LATEST NEWS

Researchers Find Breast Tumors of Asian, Black and White Women to have Different Cellular...

Editorial Team - March 27, 2023

Study Shows Disparities in Mesothelioma Survival due to Social Determinants and Limited Access

Editorial Team - March 23, 2023

Neutrophils Identified as Major Culprits in Treatment Resistance of Pancreatic Cancer

Editorial Team - March 22, 2023

Zolbetuximab Plus CAPOX Improves Survival in Select Gastric Cancers

Editorial Team - March 22, 2023

Lung Cancer Research Foundation Signs Collaboration Agreement with Daiichi Sankyo and AstraZeneca

Editorial Team - March 21, 2023

Press Releases | Cancer

CytoVeris and AdventHealth Central Florida Join Forces for Clinical... March 28, 2023
Study will explore how MarginASSURE, CytoVeris’ AI-powered imaging device, can help surgeons detect cancer in near real-time(PRWeb March 28, 2023)Read the full story at https://www.prweb.com/releases/cytoveris_and_adventhealth_central_florida_join_forces_for_clinical_study_to_improve_prostate_cancer_outcomes/prweb19246472.htm
CHC and Merck partner to advance more equitable health outcomes in... March 21, 2023
The collaboration aims to advance health equity and improve health outcomes for people at risk for breast and cervical cancers in underserved communities by creating a scalable model for prevention...(PRWeb March 21, 2023)Read the full story at https://www.prweb.com/releases/chc_and_merck_partner_to_advance_more_equitable_health_outcomes_in_breast_and_cervical_cancer_care_in_black_hispanic_and_other_underserved_populations/prweb19232973.htm
Unlocking the Power of Rick Simpson Oil: A Revolutionary Breakthrough... March 20, 2023
The power of Rick Simpson Oil (RSO) has been unlocked in an exciting new development. Used to treat a wide range of medical conditions and ailments, this oil is now more accessible than ever before.(PRWeb March 20, 2023)Read the full story at https://www.prweb.com/releases/unlocking_the_power_of_rick_simpson_oil_a_revolutionary_breakthrough_in_health_and_wellness/prweb19233768.htm

Tag: Head and Neck Cancer

Active Surveillance May be an Effective Option for Low-risk Thyroid Cancer

Why Taking a Less Personalized Approach May Increase Access to Cancer...

KEYNOTE-122: Pembrolizumab vs Chemotherapy in Platinum-Pretreated Nasopharyngeal Carcinoma

Significant Survival Benefit for Head & Neck Cancer Patients Receiving Neoadjuvant...

Study Confirms Safety of Head and Neck Cancer Surgery During the...

Survival in Head and Neck Cancer Patients Improved by Hyperfractionated Radiotherapy

Combination of EGFR and COX-2 Inhibitors may Prevent Head and Neck...

Photodynamic Therapy Shows Efficacy in Head and Neck Cancers

LATEST NEWS

Researchers Find Breast Tumors of Asian, Black and White Women to have Different Cellular...

Study Shows Disparities in Mesothelioma Survival due to Social Determinants and Limited Access

Neutrophils Identified as Major Culprits in Treatment Resistance of Pancreatic Cancer

Zolbetuximab Plus CAPOX Improves Survival in Select Gastric Cancers

Lung Cancer Research Foundation Signs Collaboration Agreement with Daiichi Sankyo and AstraZeneca

Researchers Find Breast Tumors of Asian, Black and White Women to have Different Cellular...

Study Shows Disparities in Mesothelioma Survival due to Social Determinants and Limited Access

Neutrophils Identified as Major Culprits in Treatment Resistance of Pancreatic Cancer

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...